Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer’s Disease Progression

Cited by (605)

Items 301–400 of 605

1. Multiple Roles of Paeoniflorin in Alzheimer's Disease
   Zeyu Meng, Huize Chen, Chujun Deng, Sheng-Xi Meng · 2022 · Evidence-Based Complementary and Alternative Medicine
2. The emerging role of the HTRA1 protease in brain microvascular disease
   Christof Haffner · 2023 · Frontiers in Dementia
3. Dynamic Phosphoproteomics of BRS3 Activation Reveals the Hippo Signaling Pathway for Cell Migration
   Miao Guo, Yan Zhang, Lehao Wu, Sheng Ye, Jiaqi Zhao, Zeyuan Wang, Huiyu Wang, Lu Zhang, Hua Xiao · 2023 · Journal of Proteome Research
4. Novel cuproptosis metabolism-related molecular clusters and diagnostic signature for Alzheimer’s disease
   Fang Jia, Wanhong Han, Shuang‐Qi Gao, Jian‐Wei Huang, Wujie Zhao, Zhenwei Lu, Wenpeng Zhao, Zhangyu Li, Zhanxiang Wang, Ying Guo · 2024 · Frontiers in Molecular Biosciences
5. Using in vivo intact structure for system-wide quantitative analysis of changes in proteins
   Ahrum Son, Hyunsoo Kim, Jolene K. Diedrich, Casimir Bamberger, Daniel B. McClatchy, Stuart A. Lipton, John R. Yates · 2024 · Nature Communications
6. GADD45G operates as a pathological sensor orchestrating reactive gliosis and neurodegeneration
   Tianjin Shen, Wenjiao Tai, Dongfang Jiang, Shuaipeng Ma, Xiaoling Zhong, Yuhua Zou, Chun‐Li Zhang · 2025 · Neuron
7. Cognitive Resilience in Preclinical Alzheimer's Disease: Higher Nptx2 and Vgf Levels are Associated with Reduced Cognitive Decline
   Claire L. Anderson, Alden L. Gross, Corinne A. Pettigrew, Juan P. Vazquez, Abhay Moghekar, Sungtaek Oh, Chan Hyun Na, Marilyn Albert, Paul F. Worley, Anja Soldan · 2025 · Neurobiology of Aging
8. PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors
   Andrew D. Huber, Wenwei Lin, Kwan‐Young Jung, Shyaron Poudel, Guangwei Yang, Jing Wu, Allison Carrigan, Vishwajeeth Pagala, Wei Wang, Yingxue Fu et al. · 2025 · Nature Communications
9. A double-edged sword: Exploring the neuroprotective/damaging mechanisms of complement activation in Alzheimer's disease
   Jie Wang, Jie Wu, Xiaoxi Ma, Yuhan Wu, Zhenxu Xiao, Xiao‐Wen Zhou, Ding Ding, Qianhua Zhao · 2025 · Aging and Health Research
10. A Standardized Brain Molecular Atlas: A Resource for Systems Modeling and Simulation
    Polina Shichkova, Jay S. Coggan, Henry Markram, Daniel X. Keller · 2021 · Frontiers in Molecular Neuroscience
11. Hippocampal proteomic changes in high-fat diet-induced obese mice associated with memory decline
    Ping Lu, Cun-Xiu Gao, Fei-Jian Luo, Yu-Ting Huang, Mei‐Mei Gao, Yue‐Sheng Long · 2023 · The Journal of Nutritional Biochemistry
12. Transforming neurodegenerative disorder care with machine learning: Strategies and applications
    Aya A. Galal, Ahmed A. Moustafa, Mohamed Salama · 2025 · Neuroscience
13. Post‐translational modifications linked to preclinical Alzheimer's disease–related pathological and cognitive changes
    Olamide Abiose, Jarod Rutledge, Patricia Morán Losada, Michaël E. Belloy, Edward N. Wilson, Zihuai He, Alexandra N. Trelle, Divya Channappa, America Romero, Jennifer Park et al. · 2023 · Alzheimer s & Dementia
14. The effect of effort on reward prediction error signals in midbrain dopamine neurons
    Shingo Tanaka, Jessica Elizabeth Taylor, Masamichi Sakagami · 2021 · Current Opinion in Behavioral Sciences
15. Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
    Elisa Gascón, Ana Cristina Calvo, Nora Molina, P. Zaragoza, Rosario Osta · 2024 · Biomolecules
16. Neuronal guidance signaling in neurodegenerative diseases: Key regulators that function at neuron-glia and neuroimmune interfaces
    Junichi Yuasa‐Kawada, Mariko Kinoshita-Kawada, Masaki Hiramoto, Satoru Yamagishi, Takayasu Mishima, Shin’ichiro Yasunaga, Yoshio Tsuboi, Nobutaka Hattori, Jane Y. Wu · 2025 · Neural Regeneration Research
17. Activity-dependent synthesis of Emerin gates neuronal plasticity by regulating proteostasis
    Yi Xie, Ruoxi Wang, Daniel B. McClatchy, Yuanhui Ma, Jolene K. Diedrich, Manuel Sánchez-Alavez, Michael Petrascheck, John R. Yates, Hollis T. Cline · 2025 · Cell Reports
18. Affinity peptide ligands: new tools for chasing non-canonical N -phosphoproteome
    He Wang, Xiaoyu Zhang, Dongdong Wang, Qianqian Jiang, Yue Sun, Baofeng Zhao, Zhen Liang, Guangyan Qing, Bo Jiang, Lihua Zhang et al. · 2025 · Chemical Science
19. Plasma proteomic analysis of intermuscular fat links muscle integrity with processing speed in older adults
    Toshiko Tanaka, Caterina Rosano, Xiaoning Huang, Qu Tian, Bennett A. Landman, Ann Zenobia Moore, Iva Miljkovic, Andrew Perry, Sadiya S. Khan, Ravi Kalhan et al. · 2025 · Alzheimer s & Dementia
20. -Omics approaches to study and model cell-cell interactions in engineered tissues
    Christine Stark, Sarah E. Jenison, Mai T. Ngo · 2025 · Frontiers in Chemical Engineering
21. Lipidomics and proteomics: An integrative approach for early diagnosis of dementia and Alzheimer’s disease
    Virendra Tiwari, Shubha Shukla · 2023 · Frontiers in Genetics
22. Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population
    Ruijuan Chen, Yuanjing Yi, Wenbiao Xiao, Bowen Zhong, Le Zhang, Yi Zeng · 2023 · Frontiers in Aging Neuroscience
23. Alzheimer’s disease protein relevance analysis using human and mouse model proteomics data
    Cathy Shi, William Kirby Gottschalk, Carol A. Colton, Sayan Mukherjee, Michael William Lutz · 2023 · Frontiers in Systems Biology
24. Degeneration Directory: a multi-omics web resource for degenerative diseases
    Haoteng Yan, Changfa Lu, Chen-Yang Lan, Si Wang, Wei-Qi Zhang, Zan He, Jing-Hao Hu, Jiaqi Ai, Guang-Hui Liu, Shuai Ma et al. · 2023 · Protein & Cell
25. CSF neurosecretory proteins VGF and neuroserpin in patients with Alzheimer's and Lewy body diseases
    Lorenzo Barba, Giovanni Bellomo, Patrick Oeckl, Davide Chiasserini, Lorenzo Gaetani, Edoardo Guido Torrigiani, Federico Paolini Paoletti, Petra Steinacker, Samir Abu‐Rumeileh, Lucilla Parnetti et al. · 2024 · Journal of the Neurological Sciences
26. Comparative proteomic profiling reveals a pathogenic role for the O‐GlcNAcylated AIMP2–PARP1 complex in aging‐related hepatic steatosis in mice
    Renlong Li, Yan Li, Miaomiao Tian, Haohao Zhang, Lijun Lou, Kun Liu, Jiehao Zhang, Yu Zhao, Jing Zhang, Shuangshuang Le et al. · 2021 · FEBS Letters
27. Evaluation of a Pooling Chemoproteomics Strategy with an FDA-Approved Drug Library
    Huan Sun, Ka Yang, Xue Zhang, Yingxue Fu, Jay M. Yarbro, Zhiping Wu, Ping‐Chung Chen, Taosheng Chen, Junmin Peng · 2022 · Biochemistry
28. A synaptic-astrocytic proteomic signature associated with synaptopathy in Alzheimer’s Disease
    Jessica Griffiths, Eléonore Schneegans, Harry J. Whitwell, Zhen Qiu, Beverley Notman, To Ka Dorcas Cheung, Nanet Willumsen, Paul McMahan Matthews, Seth G. N. Grant, Johanna Jackson · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
29. GPR34 regulates microglia state and loss-of-function rescues TREM2 metabolic dysfunction
    Karthik Raju, David A. Joy, Sophia M. Guldberg, Kyla Germain, Neal S. Gould, Connie Ha, David Tatarakis, Jason C. Dugas, Sonnet S. Davis, Audrey G. Reeves et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
30. Molecular subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 pathology across the spectrum of LATE and Alzheimer’s Disease
    Adam N. Trautwig, Anantharaman Shantaraman, Mingee Chung, Eric B. Dammer, Lingyan Ping, Duc M. Duong, Leonard Petrucelli, Michael Emmerson Ward, Jonathan D. Glass, Peter T. Nelson et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
31. Integrative network analysis reveals novel moderators of Aβ-Tau interaction in Alzheimer's disease
    Kitani, Akihiro, Matsui, Yusuke, for the Alzheimer’s Disease Neuroimaging Initiative · 2025 · Alzheimer's Research & Therapy
32. Pan-neurodegeneration proteomics reveals disease subtypes and molecular signatures
    Him K. Shrestha, Huan Sun, Jay M. Yarbro, DongGeun Lee, Danting Liu, Erming Wang, Meghan G. McReynolds, Nan Zhang, Boer Xie, Shu Yang et al. · 2026 · Cell
33. Transcriptional and epigenetic regulation of autophagy: mechanisms, disease relevance and therapeutic opportunities
    Jieun Seo, Seo‐Young Park, Dong Chul Lee, Wonbeak Yoo, Yong Ryoul Yang, Hwi Won Seo, Jong Lyul Park, Jae‐Yeol Joo, Kyung Chan Park, Sangwon Byun · 2026 · Signal Transduction and Targeted Therapy
34. Transmembrane protein 184B (TMEM184B) promotes expression of synaptic gene networks in the mouse hippocampus
    Elizabeth B. Wright, Erik G. Larsen, Cecilia M. Coloma-Roessle, Hannah R. Hart, Martha R. C. Bhattacharya · 2023 · BMC Genomics
35. Associations between the multitrajectory neuroplasticity of neuronavigated rTMS‐mediated angular gyrus networks and brain gene expression in AD spectrum patients with sleep disorders
    Weina Yao, Xinle Hou, Huijuan Zhou, Shengqi You, Tingyu Lv, Haifeng Chen, Zhiyuan Yang, Chang Chen, Feng Bai · 2024 · Alzheimer s & Dementia
36. Involvement of the VGF/BDNF axis in the neuropathology of Alzheimer’s disease and its potential role in diagnosis and treatment
    Elizabeth Colín-Martínez, Clorinda Arias · 2024 · Reviews in the Neurosciences
37. Superhydrophilic Nanostructured Microparticles for Enhanced Phosphoprotein Enrichment from Alzheimer’s Disease Brain
    Danyi Shang, Yongyang Song, Yun Cui, Cheng Chen, Feifei Xu, Congcong Zhu, Xuefang Dong, Yifan Chen, Shutao Wang, Xiuling Li et al. · 2025 · ACS Nano
38. Characterization of a dual degrader of MDM2 and GSPT1
    Ira Tandon, Paulina N. Esguerra, Chunrong Li, Huan Sun, Ka Yang, Zhongrui Zhang, Junmin Peng, Weiping Tang · 2025 · European Journal of Medicinal Chemistry
39. Isomerized Aβ in the brain can distinguish the status of amyloidosis in the Alzheimer’s disease spectrum
    Soumya Mukherjee, Reid A. Coyle, Céline Dubois, Keyla A. Perez, Catriona McLean, Colin Louis Masters, Blaine Russell Roberts · 2025 · Acta Neuropathologica
40. Highly efficient enrichment of intact phosphoproteins by a cadmium ion‐based co‐precipitation strategy
    Jiangfeng Li, Chongyuan Fan, Yating Yao · 2022 · Journal of Separation Science
41. Dysregulated Protein Phosphorylation in a Mouse Model of FTLD-Tau
    Isidró Ferrer, Pol Andrés‐Benito, Karina Ausín, Paz Cartas‐Cejudo, Mercedes Lachén‐Montes, José Antonio del Rı́o, Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2022 · Journal of Neuropathology & Experimental Neurology
42. In-Depth Blood Proteome Profiling by Extensive Fractionation and Multiplexed Quantitative Mass Spectrometry
    Xue Zhang, Huan Sun, Zhen Wang, Suiping Zhou, Yingxue Fu, Anthony A. High, Junmin Peng · 2023 · Methods in molecular biology
43. An intelligent algorithm of amyloid plucks to timely fault-predicting and contending dependability in IoMT
    Amir Masoud Rahmani, Seyedeh Yasaman Hosseini Mirmahaleh · 2023 · Expert Systems with Applications
44. Detecting differential transcript usage in complex diseases with SPIT
    Beril Erdogdu, Ales Varabyou, Stephanie C. Hicks, Steven L. Salzberg, Mihaela Pertea · 2024 · Cell Reports Methods
45. Profiling Protein–Protein Interactions in the Human Brain by Refined Cofractionation Mass Spectrometry
    Him K. Shrestha, Dong Geun Lee, Zhiping Wu, Zhen Wang, Yingxue Fu, Xusheng Wang, Geidy E. Serrano, Thomas G. Beach, Junmin Peng · 2024 · Journal of Proteome Research
46. Advances in human brain proteomics analysis of neurodegenerative diseases
    Yashuang Chen, Xia Wang, Benhong Xu · 2022 · Human Brain
47. Proteomics Profiling Reveals Regulation of Immune Response to Salmonella enterica Serovar Typhimurium Infection in Mice
    He Huang, Zachary Even, Zhihan Wang · 2022 · Infection and Immunity
48. Predicting gene regulatory networks from multi-omics to link genetic risk variants and neuroimmunology to Alzheimer’s disease phenotypes
    Saniya Khullar, Daifeng Wang · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
49. Longitudinal multi-omics reveals pathogenic TSC2 variants disrupt developmental trajectories of human cortical organoids derived from Tuberous Sclerosis Complex
    Weibo Niu, Shaojun Yu, Xiangru Li, Zhen Wang, Rui Chen, Christina Michalski, Arman Jahangiri, Youssef M. Zohdy, Joshua J. Chern, Ted J. Whitworth et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
50. Histone demethylase PHF2 regulates inflammatory genes in Alzheimer’s disease
    Guojun Yang, Yong Ren, Ping Zhong, P. Patel, Xiao-Qing Chen, Lei Wan, Young Ho Lee, Komal Saleem, Jian Feng, Zhen Yan · 2025 · Molecular Psychiatry
51. Amyloid-ID: photocatalytic profiling of amyloid deposits in Alzheimer’s disease tissue
    Huan Feng, Qun Zhao, Fangliang Guo, Jing Yan, Nan Zhao, Junbao Ma, Rui Xue Sun, Kaini Shen, Yusong Ge, Xin Zhang et al. · 2026 · Nature Communications
52. Limitations and opportunities in multi-omics integration for neurodevelopmental, neurodegenerative and psychiatric disorders: A systematic review
    Luiza Marques Prates Behrens, Guilherme da Silva Fernandes, Gabriela Flores Gonçalves, Franklin Vinny Medina Nunes, Rafael Diogo Weimer, José Cláudio Fonseca Moreira, Márcio Dorn · 2026 · Neuroscience
53. Insolubilome profiling defines molecular features that influence protein insolubility with aging
    Anna Stephan, Flávia A. Graça, Vishwajeeth Pagala, Liam C. Hunt, Chia-Lung Chuang, John Grime, Daniel Alford, Xusheng Wang, Anthony A. High, Junmin Peng et al. · 2026 · Developmental Cell
54. Plasma Proteomic Analysis for Alzheimer’s Disease Biomarkers, Pathways, and Subgroup Identification
    Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Ángel Balaguer, Laura Ferré‐González, Mar Peretó, Miguel Baquero, Consuelo Cháfer‐Pericás · 2025 · Journal of Proteome Research
55. Hybrid Excitable Spiking Neural Network for Cardiovascular Disease Prediction
    Asif Mehmood, Muhammad Javed Iqbal · 2023 · IEEE Access
56. Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals
    Fanhui Meng, Xiang Zhang · 2024 · The Journal of Prevention of Alzheimer s Disease
57. Dysregulated Brain Protein Phosphorylation Linked to Increased Human Tau Expression in the hTau Transgenic Mouse Model
    Isidró Ferrer, Pol Andrés‐Benito, Karina Ausín, Paz Cartas‐Cejudo, Mercedes Lachén‐Montes, José Antonio del Rı́o, Joaquín Fernández‐Irigoyen, Enrique Santamaría · 2022 · International Journal of Molecular Sciences
58. Identification of Novel Kinases of Tau Using Fluorescence Complementation Mass Spectrometry (FCMS)
    Der‐Shyang Kao, Yanyan Du, Andrew G. DeMarco, Sehong Min, Mark C. Hall, Jean‐Christophe Rochet, W. Andy Tao · 2022 · Molecular & Cellular Proteomics
59. An in-silico approach to studying a very rare neurodegenerative disease using a disease with higher prevalence with shared pathways and genes: Cerebral adrenoleukodystrophy and Alzheimer’s disease
    Yu Jeong Shim, Min Kyoung Shin, Junghyun Jung, Bongseong Koo, Wonhee Jang · 2022 · Frontiers in Molecular Neuroscience
60. Proteomic analysis of extracellular vesicles in cerebrospinal fluid of patients with Alzheimer’s disease
    Davide Chiasserini, Irene V. Bijnsdorp, Giovanni Bellomo, Pier Luigi Orvietani, Sander R. Piersma, Thang V. Pham, Lucilla Parnetti, Connie R. Jiménez · 2020 · medRxiv
61. Unbiased Classification of the Human Brain Proteome Resolves Distinct Clinical and Pathophysiological Subtypes of Cognitive Impairment
    Lenora A. Higginbotham, Kathleen Carter, Eric B. Dammer, Rafi U. Haque, Erik C. B. Johnson, Duc M. Duong, Luming Yin, Philip L. De Jager, David Alan Bennett, James J. Lah et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
62. A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
    Diana Gomes Moreira, Asad Jan · 2023 · Scientific Data
63. Therapeutically targeting the classical complement pathway with antisense oligonucleotides in Alzheimer’s disease
    Yuanyuan Wang, Tiffany Z. Wu, Alvin Gogineni, Ming‐Chi Tsai, Lukasz Jan Kielpinski, Anubha Mahajan, Shristi Pandey, Luis F. Schachner, John C. Tran, Cong Wu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
64. A compilation of reported alterations in the cerebrospinal fluid proteome in Alzheimer's disease
    Matthijs B. de Geus, Angus Clark Nairn, Steven Edward Arnold, Becky C. Carlyle · 2025 · Brain Communications
65. Activation of a nongenetic AHR-ELMSAN1 axis optimizes BET-targeting therapy and suppresses leukemia stem cells in preclinical models
    Xinyue Zhou, Steven Moreira, Cecilia Restelli, Hong Wang, Soheil Jahangiri, Sajesan Aryal, Emily Tsao, Pengcheng Zhang, Mingming Niu, Harish Kumar et al. · 2025 · Science Translational Medicine
66. The serine protease HTRA1 targets tau fibrils and provides a proteolytic barrier against pathogenic protein conformations
    Birte Hagemeier, Kamilla Ripkens, Nina Schulze, Anika Bluemke, Michal Strzala, Michelle Koci, Farnusch Kaschani, Markus Kaiser, Michael Erkelenz, Sebastian Schluecker et al. · 2025 · Journal of Biological Chemistry
67. Integrative analysis of proteomic and MRI data reveals protein associations with brain imaging features in Alzheimer’s disease
    Sotiroula Afxenti, Marilena M. Bourdakou, Eleni M. Loizidou, Margarita Zachariou, Anastasia Lambrianides, Marios Pantzaris, George M. Spyrou · 2025 · Expert Review of Proteomics
68. Longitudinal plasma proteomics: relation to incident Alzheimer's disease dementia and biomarkers
    Eun Hye Lee, Yen-Ning Huang, Tamina Park, Shiwei Liu, Nicholas K. Adzibolosu, Soumilee Chaudhuri, Changgee Chang, Paula J. Bice, Jeffrey L. Dage, Jared R. Brosch et al. · 2025 · Alzheimer s & Dementia
69. Mechanism of platelet-rich plasma in improving cyclophosphamide-induced premature ovarian failure in rats
    Ting Zhao, Xiao Xiao, Lingchuan Li · 2025 · Stem Cell Research & Therapy
70. A Review of Neuroproteomics in Neurological Disorders: The Use of Machine Learning and Deep Learning
    Gowthami Mahendran, Priyankan Kirupaharan · 2026 · Sci
71. Analyzing the glial proteome in Alzheimer’s disease
    Jong‐Heon Kim, Ruqayya Afridi, Won‐Ha Lee, Kyoungho Suk · 2023 · Expert Review of Proteomics
72. Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients
    Johnny Gutierrez, Carolin Kurz, Cosme Sandoval, Rose Edmonds, Tobias Bittner, Robert Perneczky, Anne Biever · 2024 · Journal of Alzheimer s Disease
73. Multiomics from Alzheimer’s Brains and Mesenchymal Stem Cell-Derived Extracellular Vesicles Identifies Therapeutic Potential of Specific Subpopulations to Target Mitochondrial Proteostasis
    Morteza Abyadeh, Alaattin Kaya · 2025 · Journal of Central Nervous System Disease
74. Unveiling the role of PSD95 phosphorylation after traumatic brain injury: insights from phosphoproteomic analysis
    Zhong-Xian Zhang, Junpeng Gao, Gang Li, Jin-eheng Cheng, Jiang-Tao Yu, Peng-Cheng Wang, Rui-Ning Liu, Cheng Jiang, Hao-Li Ma, Yan Zhao · 2025 · BMC Neurology
75. Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy
    Xindong Shui, Xiaoqing Zheng, Jinfeng Wu, Mi Zhang, Gamin Kim, Renxuan Chen, Lianlian Peng, Zonghai Wang, Yameng Zheng, Ling Zhang et al. · 2025 · Molecular Neurodegeneration
76. Presenilin Deficiency Increases Susceptibility to Oxidative Damage in Fibroblasts
    Kun Zou, Sadequl Islam, Yang Sun, Yuan Gao, Tomohisa Nakamura, Hiroto Komano, Taisuke Tomita, Makoto Michikawa · 2022 · Frontiers in Aging Neuroscience
77. Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles
    Xiaofeng Wu, Anton B. Iliuk, W. Andy Tao · 2022 · Advances in clinical chemistry
78. Strategies for translating proteomics discoveries into drug discovery for dementia
    Aditi Halder, Eleanor Drummond · 2023 · Neural Regeneration Research
79. Subcellular proteomics insights into Alzheimer's disease development
    Zhiyuan Liang, Hongbin Zhuang, Xueshan Cao, Guanwei Ma, Liming Shen · 2023 · PROTEOMICS - CLINICAL APPLICATIONS
80. Exploring the brain epitranscriptome: perspectives from the NSAS summit
    Sungmin Lee, Bonsang Koo, Clément Carré, André Fischer, Chuan He, Ajeet Kumar, Kathy Liu, Kate D. Meyer, Guo‐li Ming, Junmin Peng et al. · 2023 · Frontiers in Neuroscience
81. Secreted Glycoproteins That Regulate Synaptic Function: the Dispatchers in the Central Nervous System
    Haiying Gong, Conglei Zhu, Di Han, Sen Liu · 2023 · Molecular Neurobiology
82. Proteomic Signaling of Dual-Specificity Phosphatase 4 (DUSP4) in Alzheimer’s Disease
    Erming Wang, Allen L. Pan, Pritha Bagchi, Srikant Rangaraju, Nicholas T. Seyfried, Michelle E. Ehrlich, Stephen R. Salton, Bin Zhang · 2024 · Biomolecules
83. Signaling pathways in the treatment of Alzheimer’s disease with acupuncture: a narrative review
    Chao Ke, Shengtao Shan, Yan Tan, Yang Cao, Zhengrong Xie, Senjie Shi, Jiang Pan, Wei Zhang · 2024 · Acupuncture in Medicine
84. Identification of key proteins in early-onset Alzheimer’s disease based on WGCNA
    Dazhi Li, Yaxin Wang, Jinliang Wang, Qiqiang Tang · 2024 · Frontiers in Aging Neuroscience
85. Oligodendrocytes, the Forgotten Target of Gene Therapy
    Yasemin Ozgür-Gunes, Catherine Le Stunff, Pierre F Bougneres · 2024 · Cells
86. Effects of U1 Small Nuclear Ribonucleoprotein Inhibition on the Expression of Genes Involved in Alzheimer’s Disease
    Wenbo Zhu, Xuefei Wei, Yanyan Wang, Jingjing Li, Peng Lü, Kui Zhang, Bing Bai · 2020 · ACS Omega
87. An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
    Loren Ornelas, Emilda Gomez, Lindsay Panther, Aaron P. Frank, Susan Lei, Berhan Mandefro, Maria G. Bañuelos, Brandon Shelley, Julia Kaye, Leandro de Araújo Lima et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
88. Neural activity tracking identity and confidence in social information
    Nadescha Trudel, Matthew F. S. Rushworth, Marco K. Wittmann · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
89. Supervised machine learning with feature selection for prioritization of targets related to time-based cellular dysfunction in aging
    Nina Truter, Zuné Jansen van Rensburg, Radouane Oudrhiri, Raminderpal Singh, Carla Louw · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
90. PriOmics: integration of high-throughput proteomic data with complementary omics layers using mixed graphical modeling with group priors
    Robin Kosch, Katharina Limm, Annette M. Staiger, Nadine S. Kurz, Nicole Seifert, Bence Oláh, Stefan Solbrig, Marita Ziepert, Emil Chteinberg, Rainer Spang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
91. Quantitative analysis of proteostasis networks: are there applications for dementia?
    Daniel B. McClatchy · 2024 · Expert Review of Proteomics
92. Genetic and pathway complexity in Alzheimer’s disease: Insights from multi-omic data about the immune response and mitochondrial function
    Xuan Xu, Jiang Li, Fei Wang, Ke Xue, Junwen He, Xiangyu Meng, Yin Shen · 2025 · Neural Regeneration Research
93. JUMPshiny: A User‐Friendly Platform for Comprehensive Analysis and Visualization of Quantitative Proteomics Data
    Aijun Zhang, Yingxue Fu, Zuo‐Fei Yuan · 2025 · PROTEOMICS
94. Nanoscopic Mapping of the Extracellular Space in Amyloid Plaque‐rich Cortex
    Juan Estaún‐Panzano, Yulia Dembitskaya, Ivo Calaresu, Somen Nandi, Quentin Gresil, Évelyne Doudnikoff, Thierry Lesté-Lasserre, Thierry Amédée, Laurent Cognet, Laurent Groc et al. · 2025 · Advanced Science
95. Loss of mouse C19orf12 homolog disturbs tubular ER homeostasis and leads to neuroaxonal dystrophy
    Fengqin Wu, Sandra L. Siedlak, Sabina Bhatta, S Khaled, Changjuan Shao, Sandy L. Torres, Hisashi Fujioka, Wenzhang Wang · 2025 · Acta Neuropathologica Communications
96. Network-level organization of systemic inflammation reflects early Alzheimer’s-like behavioral changes
    Macy A. Seijo, Anisha Banerjee, Caesar M. Hernandez · 2025 · Scientific Reports
97. Congo Red Derived Covalent Proteotyping Sensor for Amyloid Deposits in Alzheimer’s Disease
    Huan Feng, Rui Gao, Fangliang Guo · 2025 · ACS Sensors
98. Deciphering the rules of regulated cell death subroutines by in silico methods
    Lu Zhang, Yingying Dai, Qingzhu Li, Xian Jiang, Gu He · 2025 · Journal of Advanced Research
99. NRN1 as a therapeutic target for Alzheimer's disease
    Derian A. Pugh, G. Cary, Kelsey M. Greathouse, L. Nassour-Caswell, Emma L. Hobby, N. Seyfried, Jeremy H. Herskowitz · 2026 · Alzheimer's & Dementia
100. Subtyping based on hippocampal cryptic exon burden reveals proteome-wide changes associated with TDP-43 and Alzheimer’s disease pathology
     Adam N. Trautwig, Anantharaman Shantaraman, Mingee Chung, Eric B. Dammer, Lingyan Ping, Duc M. Duong, Caroline M Watson, Leonard Petrucelli, Michael Emmerson Ward, Jonathan D. Glass et al. · 2026 · Cell Reports